Type Ⅱ diabetes is a chronic disease
● Affects more than 320 million people worldwide
● Is the fourth or fifth leading cause of death
The incidence is increasing accelerately !
Good news is that Type Ⅱ diabetes can be effectively treated with acarbose, an anti-diabetic drug produced by actinomycetes.
Actinomycetes remain the most important source of new antibiotics in nearly a decade of investigations .
However
The search for high yielding strains through experimentation is a long process
We have therefore developed an integrated software that combines
Simulate
the growth and metabolism of actinomycetes
Predict
phenotypic changes after mutation
Provide
high yielding transformation solutions